For example, several AAs, such as sanguinine and galanthamine (Figure 1), are strong anti-acetylcholinesterase inhibitors, with the latter being currently used as a treatment for symptoms of Alzheimer’s disease (AD) [11,12]. The gene discussed is ACHE; the disease is early-onset autosomal dominant Alzheimer disease.